Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 238 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2450 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2020-03-19 | 2020-07-09 | 109053 |
TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2022-12-22 | 2023-12-14 | 179180 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-03-25 | 2021-04-01 | 136300 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-07-29 | 2021-09-30 | 143242 |
TEVA-ECTOSONE | 0.1% | LOTION | Actual shortage | 2024-04-25 | 2024-05-03 | 226171 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-04-27 | 2023-07-05 | 190689 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-03-26 | 2020-04-23 | 109601 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-09-24 | 2020-10-01 | 124953 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-08-27 | 2023-12-05 | 144715 |
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 600MG 200MG 300MG | TABLET | Resolved | 2020-04-16 | 2020-05-08 | 112370 |
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195858 |
TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2020-05-01 | 2020-06-11 | 113782 |
TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-04-27 | 2023-07-06 | 190767 |
TEVA-ELETRIPTAN | 40MG | TABLET | Resolved | 2017-08-01 | 2017-10-10 | 17887 |
TEVA-ELETRIPTAN | 40MG | TABLET | Resolved | 2018-03-13 | 2018-05-11 | 42553 |
TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116678 |
TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-10-01 | 2021-01-14 | 125500 |
TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107961 |
TEVA-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-05-29 | 2021-02-25 | 116156 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
TEVA-DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-06-04 | 2019-06-04 | 85575 |
TEVA-DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97232 |
TEVA-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97235 |
TEVA-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97238 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117491 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |